Search
-
Seeing the Unseen
Humanizing AI, part three: How vision AI and AI agents are transforming product testing.
-
The State of Democracy 2025: Fake news, lack of accountability, extremism and corruption seen as top threats to democracy across Europe and the US
A new Ipsos KnowledgePanel survey offers an in-depth analysis of democratic perceptions in 9 Western countries, highlighting dissatisfaction with democracy and deep worries about its future.
-
80% of Global Influentials consistently influence buying decisions
Ipsos launches the 2025 Ipsos Global Influentials (IGI) survey to unlock insights into those in the top 20% of household incomes and company leaders.
-
The Digital Fairness Act: Battling the digital Wild West
A new Ipsos study for the European Commission exposes persistent unfair practices in the EU’s digital markets. The findings make a powerful case for the Digital Fairness Act, and the urgent need to rebuild trust.
-
Ipsos Rx Insight Store: Your On-Demand Hub for Healthcare Market Intelligence
Built on the foundation of Ipsos’ gold-standard Global Healthcare Monitors, the Ipsos Rx Insight Store offers standardised reports and dashboards that empower biopharma companies to make rapid, informed decisions for brand success.
-
European Neurologists’ Opinions on Alzheimer’s Disease
Surveyed European Neurologists Report Consensus on Early Detection and Stronger Primary Care to Advance Alzheimer’s Disease Diagnosis and Treatment
-
Ipsos Strategy3 recognised as one of the World’s Best Management Consulting Firms 2025
Ipsos Strategy3 has been recognised for the fourth year in a row.
-
Unlock your brand visibility in the AI era with Ipsos Synthesio GEO
Ipsos launches Synthesio GEO a breakthrough product offering centered around brand intelligence that enables leaders to uncover how LLMs portray their brands and categories, benchmark against competitors, and take action to shape their presence in the era of generative AI.
-
Would You Want to Know? The Paradox of Early Cancer Detection
Read our new viewpoint and delve into the paradox of early cancer detection: how expanding screening methods – particularly multi-cancer early detection tests – while life-saving, pose considerations such as psychological impacts, false positives, and ethical dilemmas.